<DOC>
	<DOCNO>NCT00002316</DOCNO>
	<brief_summary>To evaluate safety escalate dos RMP-7 administer person HIV infection cryptococcal meningitis determine MTD drug . To evaluate pharmacokinetics , include cerebrospinal fluid ( CSF ) penetration , amphotericin B administer RMP-7 .</brief_summary>
	<brief_title>The Safety Effectiveness RMP-7 Plus Amphotericin B Patients With HIV Cryptococcal Meningitis</brief_title>
	<detailed_description>Patients receive intravenous RMP-7 add conventional therapy intravenous amphotericin B ( without flucytosine ) . Treatment continue 14 day , follow-up visit 4 12 week later .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Cryptococcal</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Up 1 mg/kg amphotericin B current episode cryptococcal meningitis . Patients must : HIV infection . Acute cryptococcal meningitis . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Cardiovascular disorder include congestive heart failure , uncontrolled hypertension ( seat diastolic blood pressure &gt; 95 mm Hg ) , symptomatic ischemic heart disease ( angina ) . Orthostatic hypotension , define decrease systolic blood pressure &gt; = 20 mm Hg upon stand . Coma . Other CNS disease ( e.g. , intracranial infection ) may interfere assessment response . Opening CSF pressure &gt; = 350 mm papilledema . ( For patient recurrent disease , evidence mass effect either MRI CT excludes . ) Any concurrent disease would preclude participation study . Patients follow prior condition exclude : History bleed disorder . History active renal hepatic disease . Myocardial infarction within previous 3 month . Stroke within previous 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 1994</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Meningitis</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Antifungal Agents</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Amphotericin B</keyword>
</DOC>